Please read this important information before proceeding further. It contains legal and regulatory notices relevant to the information contained on this website.
The information contained in the Website is NOT FOR RETAIL CLIENTS - The information contained in the Website is solely intended for professional investors, defined as investors which (1) qualify as professional clients within the meaning of the Markets in Financial Instruments Directive (MiFID), (2) have requested to be treated as professional clients within the meaning of the MiFID or (3) are authorized to receive such information under any other applicable laws. The value of the investments may fluctuate. Past performance is no guarantee of future results. Investors may not get back the amount originally invested. Neither Robeco Institutional Asset Management B.V. nor any of its affiliates guarantees the performance or the future returns of any investments. If the currency in which the past performance is displayed differs from the currency of the country in which you reside, then you should be aware that due to exchange rate fluctuations the performance shown may increase or decrease if converted into your local currency.
In the UK, Robeco Institutional Asset Management B.V. (“ROBECO”) only markets its funds to institutional clients and professional investors. Private investors seeking information about ROBECO should visit our corporate website www.robeco.com or contact their financial adviser. ROBECO will not be liable for any damages or losses suffered by private investors accessing these areas.
In the UK, ROBECO Funds has marketing approval for the funds listed on this website, all of which are UCITS funds. ROBECO is authorized by the AFM and subject to limited regulation by the Financial Conduct Authority. Details about the extent of our regulation by the Financial Conduct Authority are available from us on request.
Many of the protections provided by the United Kingdom regulatory framework may not apply to investments in ROBECO Funds, including access to the Financial Services Compensation Scheme and the Financial Ombudsman Service. No representation, warranty or undertaking is given as to the accuracy or completeness of the information on this website.
If you are not an institutional client or professional investor you should therefore not proceed. By proceeding please note that we will be treating you as a professional client for regulatory purposes and you agree to be bound by our terms and conditions.
The added value of allocating to emerging markets (EM) has always been a topic of discussion among equity investors, especially when there was a large difference in performance with developed markets (DM). After a period of market decline, investors sometimes consider to lower the weight of emerging markets in their portfolio. What are the lessons that history can teach us?
In investing it is always important to take the long view. In a recent paper with data over the period from January 1988 to September 2015, we have taken a fresh look at the strategic allocation to emerging equities.
We started by investigating the long-term return characteristics of developed markets equities as measured by the MSCI World index and emerging markets equities as measured by the MSCI Emerging Markets index. The excess returns over cash of emerging markets have been roughly 75% higher than in developed markets. The volatility is 50% higher, which, when combined, results in a higher Sharpe ratio.
We also found that allocating to emerging markets increases the risk-adjusted performance of a traditional developed markets equity/bond portfolio. The portfolio volatility increases when you add emerging equity markets. But returns are even higher, from 3.7% excess return when you do not allocate to emerging markets to 4.6% excess return when you allocate 20%, resulting in a significantly higher Sharpe ratio (up from 0.38 to 0.43).
Given the potential for extra returns investors might be tempted to dynamically allocate to emerging and developed market equities. We tested the predictive power of many factors and find little to no predictive power. Only for price momentum did we find some evidence in predicting whether emerging markets will out- or underperform developed markets. If momentum works, you could argue that this implies that the weights of emerging and developed market equities in portfolio should not be rebalanced too often.
Investors can not only allocate to the emerging market equity premium, but also to other premiums within the equity market. We constructed a value and momentum index by each month considering the equally-weighted returns of the 33% most attractive stocks on respectively the earnings-to-price ratio and its 12-1 month momentum, assuming a 6-month holding period.
An emerging markets multi-factor quant portfolio consisting of a 50/50% allocation to the momentum and value factor premiums exhibits a significantly better risk-adjusted performance than the passive market portfolio. Specifically, the total return is over 6% higher than the market portfolio with similar volatility. The Sharpe ratio is 0.57 against 0.30 for the market index.
Emerging equity markets have disappointed in recent years. Yet, our empirical research shows that allocating part of an investor’s portfolio to emerging markets equity adds value and even more when the portfolio has exposures to the value and momentum factors. We therefore recommend investors to strategically allocate part of their portfolio to factor premiums in emerging equity markets.